MicroRNAs are poised to play a big role in the future understanding and treatment of rheumatoid arthritis.
Search results for: liver
Why We Are Advocates
Rheumatology advocacy efforts are paying off in 2012.
Join 125 Colleagues and Patients to Bring Rheumatology’s Message to Capitol Hill
Rheumatology professionals and patients attending the ACR’s Advocates for Arthritis conference will convene on Capitol Hill to speak with lawmakers about issues affecting the rheumatology community.
Drug Updates: Lorcaserin, Acetaminophen, and More
information on new approvals and medication safety
ACA Upheld: What Does This Mean for Rheumatology?
What does the Supreme Court decision to uphold the Affordable Care Act mean for rheumatologists?
High-Impact Rheumatology Practice Redesign
It’s time to start adapting your practice to changes in the healthcare system.
EULAR 2012: Remission the New Normal for Rheumatoid Arthritis
Advances in the rheumatology clinic are promising, two experts say.
Outstanding ARHP Program Planned for the ACR/ARHP Annual Meeting
The primary tracks at the meeting will focus on clinical practice, clinical science, basic science, and business/administration; four subtracks will include sessions relevant for educators, those interested in pediatrics, practice managers, and rheumatology trainees.
Managing an In-Office Infusion Practice
The increased utilization of infusible biologics for the treatment of rheumatic diseases has opened the door for you to provide more integrated care for your patients. Having an in-office infusion center gives you the ability to deliver this service to your patients in a familiar and supportive setting.
Patient Fact Sheet: Sjögren’s Syndrome
Sjögren’s syndrome is an inflammatory disease that can affect many different parts of the body.
- « Previous Page
- 1
- …
- 107
- 108
- 109
- 110
- 111
- …
- 130
- Next Page »